CPHC
Canterbury Park Holding Corporation
CPHC has a slight edge over GME overall, supported by lower modeled downside and stronger modeled upside.
GME
GameStop Corp.
GME offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CPHC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
CPHC's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
CPHC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.8x | $0.98 | -94% |
| Fair | 17x | $1.66 | -89% |
| Expensive | 60x | $5.98 | -62% |
| Current | 157x | $15.70 | — |
Historical ranges are pointers, not guarantees.
CPHC's PE is in its expensive range at 157x.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME has the edge over CPHC in the historical PE scenario, which offers more potential upside but is not a forecast.
CPHC Forward outlook
There aren't enough analyst estimates for CPHC to show an outlook.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
CPHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.10 | +$0.37 |
| Q2 2026 | $0.02 | -33% |
| Q1 2026 | -$0.01 | -106% |
| Q4 2025 | -$0.10 | -124% |
| Q3 2025 | -$0.27 | -129% |
| Q2 2025 | $0.03 | -96% |
| Q1 2025 | $0.16 | -91% |
| Q4 2024 | $0.42 | -80% |
CPHC has returned to profit: it earned $0.10 per share over the past year, after losing money the year before.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME has the edge over CPHC on earnings, with more consistent year-over-year improvement.
CPHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.1M | +4.2% |
| Q2 2026 | $16.2M | +3.2% |
| Q1 2026 | $13.5M | +2.8% |
| Q4 2025 | $12.4M | +3.9% |
| Q3 2025 | $18.3M | -5% |
| Q2 2025 | $15.7M | -3.3% |
| Q1 2025 | $13.1M | -6.8% |
| Q4 2024 | $12M | -4.4% |
CPHC has the edge over GME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.9% | +3.2 points |
| Q2 2026 | 1.8% | -1 points |
| Q1 2026 | 7.8% | +2.9 points |
| Q4 2025 | 2.6% | +3.5 points |
| Q3 2025 | 5.7% | -13 points |
| Q2 2025 | 2.8% | -4.2 points |
| Q1 2025 | 4.9% | -7.6 points |
| Q4 2024 | -0.8% | -5.5 points |
CPHC's operating margin was 8.9% last quarter, up 3.2 points from the same quarter a year ago.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME has the edge over CPHC on profitability, with a higher operating margin.
CPHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +$3.1M |
| Q2 2026 | $3.6M | +11% |
| Q1 2026 | $2.6M | +3.6% |
| Q4 2025 | -$611.3K | +$6.1M |
| Q3 2025 | -$395.3K | -$395.3K |
| Q2 2025 | $3.2M | +78% |
| Q1 2025 | $2.5M | +$3.1M |
| Q4 2024 | -$6.7M | -$5.7M |
CPHC's free cash flow has turned positive after three years mostly in the red: $8M over the past year.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME has the edge over CPHC on cash flow, with more consistent year-over-year improvement.
CPHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +54.4K shares |
| 1 year | +2.1% | +107K shares |
| 3 years | +5.2% | +258K shares |
| 5 years | +8.8% | +422K shares |
| Available history | +13% | +601K shares |
CPHC has the edge over GME on shareholder dilution, with a more favorable share count trend.
GME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +300K shares |
| 1 year | +8.4% | +46.1M shares |
| 3 years | +94% | +288M shares |
| 5 years | +104% | +302M shares |
| Available history | +80% | +264M shares |
GME has 593M diluted shares, up 8.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | $21.8M |
| Q4 2019 | $114M |
CPHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -1.8x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -2.0x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.2x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
CPHC has more cash than debt.
GME Net Leverage
CPHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.0 | Neutral |
| Stochastic | 70.6 | Neutral |
CPHC's weekly RSI is 48 (neutral) and its Stochastic is 71 (neutral).
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
CPHC PE vs Consumer Cyclical Sector
| Metric | CPHC | Sector median | Relative |
|---|---|---|---|
| PE | 157x | 18x | 771% above |
| PE % | 92 | 47 | 45 pts above |
CPHC is trading at 157x earnings, a 771% premium to the Consumer Cyclical sector's median of 18x.
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME has the edge over CPHC on valuation relative to its sector.
CPHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.8 | 0.3% below |
| 20 week MA | $15.8 | 0.4% below |
| 50 week MA | $15.7 | 0.3% above |
| 100 week MA | $16.9 | 7% below |
| 200 week MA | $19.5 | 19% below |
CPHC's trend is mixed: it's above one of its five weekly moving averages, and 19% below its 200-week average.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME has the edge over CPHC on trend strength, trading above more of its moving averages.
CPHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.4 | $12.4 | -0.5% |
| 2021 | $12.4 | $17.6 | +42% |
| 2022 | $17.6 | $28.8 | +64% |
| 2023 | $28.8 | $20.4 | -29% |
| 2024 | $20.4 | $21.9 | +7.2% |
| 2025 | $21.9 | $15.3 | -30% |
| 2026 YTD | $15.3 | $15.7 | +2.5% |
CPHC has finished lower in three of the last six years. It's up 2.5% so far in 2026.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME has the edge over CPHC on returns for 2026, with the stronger performance.